News in Numbers

Eli Lilly has tapped Huntsville, Alabama, as the location for its third orforglipron manufacturing facility. Set to enter construction in 2026, the $6bn site will create 3,000 construction roles.

4.6 billion people worldwide still lack access to essential health services and 2.1 billion people experience financial hardship to access health care, as per a new report by the World Health Organization (WHO).

The AIDS Vaccine Advocacy Coalition estimates that 2.5 million people who relied on PrEP in 2024 lost access to their medications in 2025 due solely to donor funding cuts.

The bipolar disorder (BD) market across the seven major markets is forecast to hit a $9.4bn valuation in 2034, according to GlobalData analysis.

M&As in the pharmaceutical industry have witnessed a 31% increase in total deal value in 2025 year-to-date (YTD), as per GlobalData analysis.